Target intelligence / Profile preview

50S ribosomal subunit – 23S ribosomal RNA cryptic site (23S rRNA cryptic site)

Target
23S rRNA cryptic site
Molecular classification
Ribosomal RNA, Ribonucleoprotein complex, Other
01

Overview

The 50S ribosomal subunit – 23S ribosomal RNA cryptic site is a secondary binding pocket for aminoglycoside antibiotics, located within the large ribosomal subunit of bacteria (Sullivan et al., 2018). While aminoglycosides are primarily known for binding to the 16S rRNA of the 30S subunit to interfere with genetic code translation, the discovery of this cryptic site in the 23S rRNA has revealed a dual-action mechanism that contributes significantly to their bactericidal efficacy (Ying et al., 2019). Binding at this site is thought to induce severe translational errors, leading to the production of misfolded or truncated proteins. These aberrant proteins subsequently integrate into the bacterial cell membrane, causing structural damage and increasing permeability, which ultimately results in rapid cell death (Wallace et al., 1973; Borovinskaya et al., 2007). This site is of particular interest in the study of antibiotic resistance, as modifications in the 23S rRNA can influence drug susceptibility. Furthermore, the structural similarity between bacterial 23S rRNA and human mitochondrial rRNA at this site underlies some of the characteristic toxicities associated with aminoglycoside therapy, such as ototoxicity and nephrotoxicity (Waters and Tadi, 2024).

Other names
50S aminoglycoside binding site23S rRNA secondary binding site50S subunit cryptic pocket
02

Mechanism of action

Binding to the 23S rRNA cryptic site induces translational errors and promotes the production of misfolded proteins that integrate into and destabilize the bacterial cell membrane.

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activityRibosomal assembly
04

Disease associations

Infection
05

Safety considerations

Mitochondrial toxicityOtotoxicityNephrotoxicityAntibiotic resistance
06

Interacting drugs

Gentamicin

6 more in the full profile.

07

Biomarkers

23S ribosomal RNA mutations (e.g., A2058, A2059)Aminoglycoside-modifying enzymes (AMEs)16S ribosomal RNA methyltransferases

Beyond the preview

Go deeper on 50S ribosomal subunit – 23S ribosomal RNA cryptic site (23S rRNA cryptic site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S ribosomal subunit – 23S ribosomal RNA cryptic site (23S rRNA cryptic site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call